Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.94
-0.04 (-0.50%)
Nov 21, 2024, 4:00 PM EST - Market closed
Treace Medical Concepts Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 202.86 | 187.12 | 141.84 | 94.42 | 57.37 | 39.42 |
| Revenue Growth (YoY) | 16.14% | 31.92% | 50.22% | 64.59% | 45.54% | - |
| Cost of Revenue | 39.33 | 35.18 | 25.53 | 16.89 | 12.47 | 7.63 |
| Gross Profit | 163.53 | 151.94 | 116.31 | 77.53 | 44.9 | 31.79 |
| Selling, General & Admin | 206.27 | 187.93 | 137.57 | 83.84 | 38.19 | 30.25 |
| Research & Development | 19.37 | 15.28 | 13.58 | 10.2 | 5.85 | 5.07 |
| Operating Expenses | 225.63 | 203.2 | 151.15 | 94.04 | 44.04 | 35.32 |
| Operating Income | -62.1 | -51.27 | -34.84 | -16.51 | 0.86 | -3.54 |
| Interest Expense | -5.25 | -5.17 | -4.4 | -4.06 | -2.78 | -0.84 |
| Interest & Investment Income | 5.69 | 6.73 | 1.31 | 0.02 | - | 0.11 |
| Other Non Operating Income (Expenses) | 0.3 | 0.34 | -0.06 | 0 | -1.75 | - |
| EBT Excluding Unusual Items | -61.36 | -49.36 | -37.99 | -20.55 | -3.67 | -4.27 |
| Asset Writedown | - | - | -0.35 | - | - | - |
| Other Unusual Items | -0.16 | -0.16 | -4.48 | - | - | - |
| Pretax Income | -61.52 | -49.53 | -42.82 | -20.55 | -3.67 | -4.27 |
| Net Income | -61.52 | -49.53 | -42.82 | -20.55 | -3.67 | -4.27 |
| Preferred Dividends & Other Adjustments | - | - | - | 0.2 | 0.64 | 0.64 |
| Net Income to Common | -61.52 | -49.53 | -42.82 | -20.75 | -4.31 | -4.91 |
| Shares Outstanding (Basic) | 62 | 61 | 55 | 48 | 37 | 37 |
| Shares Outstanding (Diluted) | 62 | 61 | 55 | 48 | 37 | 37 |
| Shares Change (YoY) | 4.46% | 10.09% | 14.17% | 30.61% | 0.43% | - |
| EPS (Basic) | -0.99 | -0.81 | -0.77 | -0.43 | -0.12 | -0.13 |
| EPS (Diluted) | -0.99 | -0.81 | -0.77 | -0.43 | -0.12 | -0.13 |
| Free Cash Flow | -43.2 | -46.03 | -45.49 | -19.9 | -5.56 | -8.88 |
| Free Cash Flow Per Share | -0.70 | -0.76 | -0.82 | -0.41 | -0.15 | -0.24 |
| Gross Margin | 80.61% | 81.20% | 82.00% | 82.11% | 78.26% | 80.64% |
| Operating Margin | -30.61% | -27.40% | -24.57% | -17.49% | 1.49% | -8.97% |
| Profit Margin | -30.33% | -26.47% | -30.19% | -21.97% | -7.51% | -12.44% |
| Free Cash Flow Margin | -21.29% | -24.60% | -32.07% | -21.07% | -9.70% | -22.54% |
| EBITDA | -54.63 | -46.39 | -32.71 | -15.83 | 2.07 | -2.74 |
| EBITDA Margin | -26.93% | -24.79% | -23.06% | -16.76% | 3.60% | -6.96% |
| D&A For EBITDA | 7.48 | 4.88 | 2.13 | 0.69 | 1.21 | 0.79 |
| EBIT | -62.1 | -51.27 | -34.84 | -16.51 | 0.86 | -3.54 |
| EBIT Margin | -30.61% | -27.40% | -24.57% | -17.49% | 1.49% | -8.97% |
| Advertising Expenses | - | 16.1 | 15 | 13 | 3.1 | 1.9 |
Source: S&P Capital IQ. Standard template. Financial Sources.